Elucidation of the Strongest Predictors of Cardiovascular Events in Patients with Heart Failure

Hiroki Fukuda, Kazuhiro Shindo, Mari Sakamoto, Tomomi Ide, Shintaro Kinugawa, Arata Fukushima, Hiroyuki Tsutsui, Shin Ito, Akira Ishii, Takashi Washio, Masafumi Kitakaze

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: In previous retrospective studies, we identified the 50 most influential clinical predictors of cardiovascular outcomes in patients with heart failure (HF). The present study aimed to use the novel limitless-arity multiple-testing procedure to filter these 50 clinical factors and thus yield combinations of no more than four factors that could potentially predict the onset of cardiovascular events. A Kaplan–Meier analysis was used to investigate the importance of the combinations. Methods: In a multi-centre observational trial, we prospectively enrolled 213 patients with HF who were hospitalized because of exacerbation, discharged according to HF treatment guidelines and observed to monitor cardiovascular events. After the observation period, we stratified patients according to whether they experienced cardiovascular events (rehospitalisation or cardiovascular death). Findings: Among 77,562 combinations of fewer than five clinical parameters, we identified 151 combinations that could potentially explain the occurrence of cardiovascular events. Of these, 145 combinations included the use of inotropic agents, whereas the remaining 6 included the use of diuretics without bradycardia or tachycardia, suggesting that the high probability of cardiovascular events is exclusively determined by these two clinical factors. Importantly, Kaplan–Meier curves demonstrated that the use of inotropes or of diuretics without bradycardia or tachycardia were independent predictors of a markedly worse cardiovascular prognosis. Interpretation: Patients treated with either inotropic agents or diuretics without bradycardia or tachycardia were at a higher risk of cardiovascular events. The uses of these drugs, regardless of heart rate, are the strongest clinical predictors of cardiovascular events in patients with HF.

Original languageEnglish
Pages (from-to)185-195
Number of pages11
JournalEBioMedicine
Volume33
DOIs
Publication statusPublished - Jul 1 2018

Fingerprint

Heart Failure
Bradycardia
Diuretics
Tachycardia
Retrospective Studies
Heart Rate
Observation
Guidelines
Testing
Pharmaceutical Preparations
Therapeutics

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Fukuda, H., Shindo, K., Sakamoto, M., Ide, T., Kinugawa, S., Fukushima, A., ... Kitakaze, M. (2018). Elucidation of the Strongest Predictors of Cardiovascular Events in Patients with Heart Failure. EBioMedicine, 33, 185-195. https://doi.org/10.1016/j.ebiom.2018.06.001

Elucidation of the Strongest Predictors of Cardiovascular Events in Patients with Heart Failure. / Fukuda, Hiroki; Shindo, Kazuhiro; Sakamoto, Mari; Ide, Tomomi; Kinugawa, Shintaro; Fukushima, Arata; Tsutsui, Hiroyuki; Ito, Shin; Ishii, Akira; Washio, Takashi; Kitakaze, Masafumi.

In: EBioMedicine, Vol. 33, 01.07.2018, p. 185-195.

Research output: Contribution to journalArticle

Fukuda, H, Shindo, K, Sakamoto, M, Ide, T, Kinugawa, S, Fukushima, A, Tsutsui, H, Ito, S, Ishii, A, Washio, T & Kitakaze, M 2018, 'Elucidation of the Strongest Predictors of Cardiovascular Events in Patients with Heart Failure', EBioMedicine, vol. 33, pp. 185-195. https://doi.org/10.1016/j.ebiom.2018.06.001
Fukuda, Hiroki ; Shindo, Kazuhiro ; Sakamoto, Mari ; Ide, Tomomi ; Kinugawa, Shintaro ; Fukushima, Arata ; Tsutsui, Hiroyuki ; Ito, Shin ; Ishii, Akira ; Washio, Takashi ; Kitakaze, Masafumi. / Elucidation of the Strongest Predictors of Cardiovascular Events in Patients with Heart Failure. In: EBioMedicine. 2018 ; Vol. 33. pp. 185-195.
@article{9ebca717bda34aa887ea740f4ecb8b20,
title = "Elucidation of the Strongest Predictors of Cardiovascular Events in Patients with Heart Failure",
abstract = "Background: In previous retrospective studies, we identified the 50 most influential clinical predictors of cardiovascular outcomes in patients with heart failure (HF). The present study aimed to use the novel limitless-arity multiple-testing procedure to filter these 50 clinical factors and thus yield combinations of no more than four factors that could potentially predict the onset of cardiovascular events. A Kaplan–Meier analysis was used to investigate the importance of the combinations. Methods: In a multi-centre observational trial, we prospectively enrolled 213 patients with HF who were hospitalized because of exacerbation, discharged according to HF treatment guidelines and observed to monitor cardiovascular events. After the observation period, we stratified patients according to whether they experienced cardiovascular events (rehospitalisation or cardiovascular death). Findings: Among 77,562 combinations of fewer than five clinical parameters, we identified 151 combinations that could potentially explain the occurrence of cardiovascular events. Of these, 145 combinations included the use of inotropic agents, whereas the remaining 6 included the use of diuretics without bradycardia or tachycardia, suggesting that the high probability of cardiovascular events is exclusively determined by these two clinical factors. Importantly, Kaplan–Meier curves demonstrated that the use of inotropes or of diuretics without bradycardia or tachycardia were independent predictors of a markedly worse cardiovascular prognosis. Interpretation: Patients treated with either inotropic agents or diuretics without bradycardia or tachycardia were at a higher risk of cardiovascular events. The uses of these drugs, regardless of heart rate, are the strongest clinical predictors of cardiovascular events in patients with HF.",
author = "Hiroki Fukuda and Kazuhiro Shindo and Mari Sakamoto and Tomomi Ide and Shintaro Kinugawa and Arata Fukushima and Hiroyuki Tsutsui and Shin Ito and Akira Ishii and Takashi Washio and Masafumi Kitakaze",
year = "2018",
month = "7",
day = "1",
doi = "10.1016/j.ebiom.2018.06.001",
language = "English",
volume = "33",
pages = "185--195",
journal = "EBioMedicine",
issn = "2352-3964",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Elucidation of the Strongest Predictors of Cardiovascular Events in Patients with Heart Failure

AU - Fukuda, Hiroki

AU - Shindo, Kazuhiro

AU - Sakamoto, Mari

AU - Ide, Tomomi

AU - Kinugawa, Shintaro

AU - Fukushima, Arata

AU - Tsutsui, Hiroyuki

AU - Ito, Shin

AU - Ishii, Akira

AU - Washio, Takashi

AU - Kitakaze, Masafumi

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Background: In previous retrospective studies, we identified the 50 most influential clinical predictors of cardiovascular outcomes in patients with heart failure (HF). The present study aimed to use the novel limitless-arity multiple-testing procedure to filter these 50 clinical factors and thus yield combinations of no more than four factors that could potentially predict the onset of cardiovascular events. A Kaplan–Meier analysis was used to investigate the importance of the combinations. Methods: In a multi-centre observational trial, we prospectively enrolled 213 patients with HF who were hospitalized because of exacerbation, discharged according to HF treatment guidelines and observed to monitor cardiovascular events. After the observation period, we stratified patients according to whether they experienced cardiovascular events (rehospitalisation or cardiovascular death). Findings: Among 77,562 combinations of fewer than five clinical parameters, we identified 151 combinations that could potentially explain the occurrence of cardiovascular events. Of these, 145 combinations included the use of inotropic agents, whereas the remaining 6 included the use of diuretics without bradycardia or tachycardia, suggesting that the high probability of cardiovascular events is exclusively determined by these two clinical factors. Importantly, Kaplan–Meier curves demonstrated that the use of inotropes or of diuretics without bradycardia or tachycardia were independent predictors of a markedly worse cardiovascular prognosis. Interpretation: Patients treated with either inotropic agents or diuretics without bradycardia or tachycardia were at a higher risk of cardiovascular events. The uses of these drugs, regardless of heart rate, are the strongest clinical predictors of cardiovascular events in patients with HF.

AB - Background: In previous retrospective studies, we identified the 50 most influential clinical predictors of cardiovascular outcomes in patients with heart failure (HF). The present study aimed to use the novel limitless-arity multiple-testing procedure to filter these 50 clinical factors and thus yield combinations of no more than four factors that could potentially predict the onset of cardiovascular events. A Kaplan–Meier analysis was used to investigate the importance of the combinations. Methods: In a multi-centre observational trial, we prospectively enrolled 213 patients with HF who were hospitalized because of exacerbation, discharged according to HF treatment guidelines and observed to monitor cardiovascular events. After the observation period, we stratified patients according to whether they experienced cardiovascular events (rehospitalisation or cardiovascular death). Findings: Among 77,562 combinations of fewer than five clinical parameters, we identified 151 combinations that could potentially explain the occurrence of cardiovascular events. Of these, 145 combinations included the use of inotropic agents, whereas the remaining 6 included the use of diuretics without bradycardia or tachycardia, suggesting that the high probability of cardiovascular events is exclusively determined by these two clinical factors. Importantly, Kaplan–Meier curves demonstrated that the use of inotropes or of diuretics without bradycardia or tachycardia were independent predictors of a markedly worse cardiovascular prognosis. Interpretation: Patients treated with either inotropic agents or diuretics without bradycardia or tachycardia were at a higher risk of cardiovascular events. The uses of these drugs, regardless of heart rate, are the strongest clinical predictors of cardiovascular events in patients with HF.

UR - http://www.scopus.com/inward/record.url?scp=85048930452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048930452&partnerID=8YFLogxK

U2 - 10.1016/j.ebiom.2018.06.001

DO - 10.1016/j.ebiom.2018.06.001

M3 - Article

VL - 33

SP - 185

EP - 195

JO - EBioMedicine

JF - EBioMedicine

SN - 2352-3964

ER -